Seller record · Telehealth service

altRx

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis, lot number or testing claim appears on the site. Home, about, contact, terms, privacy and the frequently asked questions carry none. 1 more criterion also fails; see the table below.

At a glance

altRxTelehealth service

6/8criteria passed
Price
GLP-1 $89 a month, GLP-1 plus GIP $149
Sells
compounded semaglutide, compounded tirzepatide
FDA letters
1 on file
Visit altRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth membership selling compounded semaglutide and tirzepatide. It names four filling pharmacies with street addresses, and an FDA warning letter names the operating entity.

Operating entity Trinity Healthcare Supply LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSaltRx's about page
S2Prescription gatingPASSaltRx's website
S3Pharmacy identificationPASSaltRx's about page
S4Compounding disclosurePASSaltRx's about page
S5Analytical documentationFAILaltRx's website
S6Business addressFAILaltRx's privacy page
S7Price disclosurePASSaltRx's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSMedical services, including clinical evaluation and prescribing, are stated to be provided by OpenLoop Healthcare Partners, PC and its affiliated professional medical practices.Source: altRx's about page.
S2PASSAn eligibility intake headed check your eligibility for GLP-1 treatment stops the order, before any product or payment screen.Source: altRx's website.
S3PASSFour pharmacies named with street addresses and telephone numbers: RedRock Pharmacy in St. George, Health Warehouse in Florence, Precision Medicine in Bellmore, and Triad Rx in Daphne.Source: altRx's about page.
S4PASSA reader-visible page states the medications are compounded and are not FDA approved or evaluated by the FDA.Source: altRx's about page.
S5FAILNo certificate of analysis, lot number or testing claim appears on the site. Home, about, contact, terms, privacy and the frequently asked questions carry none.Source: altRx's website.
S6FAILThe seller prints no street address of its own. Footer, contact, terms and privacy carry one postal address between them, and it belongs to Openloop, Inc. in Alpharetta, Georgia, the clinical platform rather than the seller.Source: altRx's privacy page.
S7PASSPrices printed on the homepage: 89 dollars monthly for GLP-1 and 149 dollars monthly for GLP-1 plus GIP, described as the same price every month.Source: altRx's website.
S8PASSFDA warning letter 728236, June 2026, names Trinity HealthCare Supply, LLC dba altRx and alleges misbranding; no FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 728236, issued June 2026, to Trinity HealthCare Supply, LLC dba altRxA pictured label identifies altRx as the compounder of semaglutide and tirzepatide products when it is not, and claims that the products are clinically proven represent them as FDA-approved when they are not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit altRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.